Please note that the details of this Challenge are no longer open. This challenge is awarded and is no longer accepting new submissions. You can:
Challenge Biomarkers for Progressive Multifocal Leukoencephalopathy (PML)
Biomarkers for Progressive Multifocal Leukoencephalopathy (PML)
STATUS: Awarded
Active Solvers: 259
Posted: Jun 21 2010
Challenge ID: 9522323
 
Share Challenge Share
Abstract
This Challenge requires suggestions for biomarkers predictive of Progressive Multifocal Luekoencephalopathy (PML).

This is a Theoretical Challenge that requires only a written proposal to be submitted. The Challenge award will be contingent upon theoretical evaluation of the proposal by the Seeker. The Seeker reserves the right to make partial awards to Solvers in exchange for non-exclusive rights.
Overview
PML is a severe and, currently, untreatable neurodegenerative disease associated both with JC Virus infection and suppression of the host immune system.

This Challenge seeks a biomarker or biomarkers, which could enable clinicians to take appropriate actions prior to onset of disease.
What is InnoCentive?
InnoCentive is the global innovation marketplace where creative minds solve some of the world's most important problems for cash awards up to $1 million. Commercial, governmental and humanitarian organizations engage with InnoCentive to solve problems that can impact humankind in areas ranging from the environment to medical advancements.

What is a Theoretical IP Transfer Challenge?

An InnoCentive Theoretical Challenge builds upon an idea but is not yet a proof of concept. A solution to a Theoretical Challenge will solidify the Solver's concept with detailed descriptions, specifications and requirements necessary to bringing a good idea closer to becoming an actual product or service.

This Challenge is a Theoretical-IP Transfer Challenge, meaning that Solvers must relinquish all rights to the Intellectual Property (IP) for which they are awarded. By contrast, Theoretical-Licensing means that the Seeker is requesting non-exclusive rights to use the winning solution. For these forms of a Theoretical Challenge, Solvers that do not win retain the rights to their solution after the evaluation period is complete. The Seeker retains no rights to any IP not awarded.

Share This Challenge
InnoCentive Trust Partners